Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children

Epidemiology and Infection

Volumn 141, Issue 3, 2013, Pages 631-638

  Dukers Muijrers, N H T M ^a,b   Stobberingh, E ^b   Beisser, P ^b   Boesten, R C H ^a   Jacobs, P ^c   Hoebe, C J P A ^a,b  

^a South Limburg Public Health Service   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Infectious Diseases   (Netherlands)

Author keywords

Antibiotic resistance; children; day care centres; Staphylococcus aureus; Streptococcus pneumoniae; vaccination

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; NONHUMAN; NOSE SMEAR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

AGE FACTORS; CARRIER STATE; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; COINFECTION; CROSS-SECTIONAL STUDIES; HUMANS; INFANT; NETHERLANDS; NOSE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84876909219     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881200115X     Document Type: Article

References (34)

1. O'Brien KL, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years : global estimates. Lancet 2009; 374: 893-902.
2. Black SB, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatric Infectious Disease Journal 2002; 21: 810-815.
3. Hansen J, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatric Infectious Disease Journal 2006; 25: 779-781.
4. Klugman KP, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine 2003; 349: 1341-1348.
5. Lucero MG, et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines : A randomized, double-blind, placebo-controlled trial. Pediatric Infectious Disease Journal 2009; 28: 455-462.
6. Rodenburg GD, et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerging Infectious Diseases 2010; 16: 816-823.
7. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. International Journal of Infectious Diseases 2009; 14: e197-209.
8. Xu Q, et al. Novel type of Streptococcus pneumoniae causing multidrug-resistant acute otitis media in children. Emerging Infectious Diseases 2009; 15: 547-551.
9. Tan TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Current Opinion in Infectious Diseases 2003; 16: 271-277.
10. Hanage WP, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010; 2: 80-84.
11. Bogaert D, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004; 363: 1871-1872.
12. Regev-Yochay G, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. Journal of the American Medical Association 2004; 292: 716-720.
13. Quintero B, et al. Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. European Journal of Clinical Microbiology Infectious Diseases 2011; 30: 7-19.
14. McNally LM, et al. Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. Journal of Infectious Diseases 2006; 194: 385-390.
15. van Gils EJM, et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS ONE 2011; 6: e20229.
16. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. American Journal of Medicine 2008; 121: 258-264.
17. Lee GM, et al. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infectious Diseases 2009; 9: 110.
18. Jacoby P, et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine 2007;25: 2458-2464.
19. van Gils EJ, et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children : A randomized controlled trial. Journal of the American Medical Association 2009; 302: 159-167.
20. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378: 1962-1973.
21. Jansen AG, et al. Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits. Vaccine 2009; 27: 2394-2401.
22. van Gils EJ, et al. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. Journal of the American Medical Association 2010; 304: 1099-1106.
23. Spijkerman J, et al. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerging Infectious Diseases 2011; 17: 584-591.
24. Weinberger DM, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clinical Infectious Diseases 2010; 51: 692-699.
25. Elberse KE, et al. Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands. Vaccine 2010; 29: 1029-1035.
26. Regev-Yochay G, et al. The pneumococcal pilus predicts the absence of Staphylococcus aureus co-colonization in pneumococcal carriers. Clinical Infectious Diseases 2009; 48: 760-763.
27. Melles DC, et al. Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. Microbiology 2007; 153: 686-692.
28. Lebon A, et al. The inverse correlation between Staphylococcus aureus and Streptococcus pneumoniae colonization in infants is not explained by differences in serum antibody levels in the Generation R Study. Clinical and Vaccine Immunology 2011; 18: 180-183.
29. Basset A, et al. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. Journal of Clinical Microbiology 2007; 45: 1684-1689.
30. Weinberger DM, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathogens 2009; 5: e1000476.
31. Health Council of The Netherlands. Vaccination of infants against pneumococcal infections (2). (http://www.gezondheidsraad.nl/sites/default/files/ Summary%20 pneumo kokkeninfecties%202.pdf). Health Council of The Netherlands, The Hague, 2010.
32. Paradiso PR. Advances in pneumococcal disease prevention : 13-valent pneumococcal conjugate vaccine for infants and children. Clinical Infectious Diseases 2011; 52: 1241-1247.
33. van Lier EA, et al. High vaccination coverage of the National Immunization Programme in the Netherlands [in Dutch]. Nederlands Tijdschrift voor Geneeskunde 2009; 153: 950-957.
34. Miller M, et al. Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and-uninfected drug users. Clinical Infectious Diseases 2007; 45: 343-346.